FAKTOR-OPTIONSSCHEIN - HALEON Stock

Certificat

DE000MB30X67

Real-time Bid/Ask 11:10:51 2024-05-21 EDT
4.4 EUR / 4.43 EUR -3.60% Intraday chart for FAKTOR-OPTIONSSCHEIN - HALEON
Current month-6.53%
1 month+13.93%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-21 4.38 -4.37%
24-05-20 4.58 +7.26%
24-05-17 4.27 -0.70%
24-05-16 4.3 -0.69%
24-05-15 4.33 +5.87%

Delayed Quote Börse Stuttgart

Last update May 21, 2024 at 09:33 am

More quotes

Static data

Product typeExotische Produkte
Buy / SellCALL
Underlying HALEON PLC
Issuer Morgan Stanley
WKN MB30X6
ISINDE000MB30X67
Date issued 2023-01-31
Strike 276.7 p
Maturity Unlimited
Parity 0.15 : 1
Emission price 10
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 15.14
Lowest since issue 3.25
Spread 0.03
Spread %0.67%

Company Profile

Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (27.7%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (23.5%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (18.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - respiratory medicines (15.4%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (14.5%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (40.2%), North America (37.1%), and Asia/Pacific (22.7%).
Sector
-
More about the company

Ratings for Haleon plc

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Haleon plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
3.32 GBP
Average target price
3.62 GBP
Spread / Average Target
+9.04%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW